Movano health plans to timely request a hearing before a nasdaq hearings panel

Received delisting notice from nasdaq related to minimum bid price requirement and late filing of the form 10-q for the period ended march 31, 2025 pleasanton, calif. , july 11, 2025 /prnewswire/ -- movano health (nasdaq: move ) (the "company") announced today that, on july 7, 2025, it received a delisting determination from the nasdaq capital market with respect to the $1.00 per share bid price requirement (the "bid price requirement"), as set forth in listing rule 5550(a)(2), and the late filing requirement, as set forth in listing rule 5250(c)(1), given the delay in filing its form 10-q for the quarter ended march 31, 2025 (the "filing requirement")(together, the "notice").
MOVE Ratings Summary
MOVE Quant Ranking